COMMUNIQUÉS West-GlobeNewswire

Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
08/09/2026
RAMAT GAN, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological [...]
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
ZUG, Switzerland and BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th Annual Global [...]
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
08/09/2026
Dr. Soon-Shiong will Join PDS Biotech’s Board of Directors PDS Biotech Plans to Progress Development of PDS0301 Immunocytokine in Solid Tumors PRINCETON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology [...]
Tempest to Present at the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
BRISBANE, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company pioneering the development of advanced in vivo CAR-T therapies for [...]
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
08/09/2026
AUSTIN, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients [...]
Merakris Therapeutics Launches Patent-Pending AmnioSurge™ With 360 Medical, Opening New Surgical Revenue Channel
08/09/2026
Procedure-specific biologic technology combines surgeon training, scalable tissue processing and a capital-efficient commercialization model RESEARCH TRIANGLE PARK, N.C., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Merakris [...]
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
08/09/2026
SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (Surrozen or the Company) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to [...]
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
08/09/2026
HUDSON, Mass. and YOKNEAM ILLIT, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized [...]
Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome
08/09/2026
Second Rare Pediatric Disease (RPD) Designation for QRX003 FDA Previously Granted RPD Designation for QRX003 in Netherton Syndrome If a New Drug Application (NDA) for QRX003 Is Approved for Peeling Skin Syndrome, Quoin [...]
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
08/09/2026
VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (“ Optimi ” or the “ Company ”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic [...]
Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026
08/09/2026
BURLINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present [...]
Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer
08/09/2026
BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Sparrow Pharmaceuticals , a targeted cardiometabolic therapeutics company, today announced the appointment of George Eldridge as Chief Financial Officer. Mr. Eldridge brings [...]
Bone Biologics Expands Trial Sites
08/09/2026
Addition of three sites strengthens expectation to complete enrollment by year-end 2026 BURLINGTON, MA, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) (“Bone Biologics” or the “ [...]
NeuroStar Advances Practice Innovation with First-Ever TMS Integration with an EHR/EMR System
08/09/2026
First-of-Its-Kind Integration Connects TrakStar and AdvancedMD, Delivering TMS Care Across Clinical, Operational, and Billing Workflows MALVERN, Pa., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), [...]
NeOnc' Phase 2 Data Could Put Cancer on the Ropes
08/09/2026
NeOnc Looking to Turn Phase 2 Win into FDA Action DENVER, Sept. 08, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) – For NeOnc Technologies Holdings (NASDAQ: NTHI) , the Phase 2a question has been answered. Now comes the [...]
Vivos Therapeutics Announces Material Debt Reduction
08/09/2026
Company Continues to Make Significant Progress to Enhance Stockholders' Equity and Satisfy Nasdaq Listing Requirements LITTLETON, Colo., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or "the [...]
Tria Federal Joins Appian Public Sector Partner Program to Power Federal Missions
08/09/2026
Partnership with Appian will help agencies deliver mission outcomes at scale, on time and under pressure ARLINGTON, Va., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Tria Federal (Tria) announced today that it has become an [...]
HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells
08/09/2026
Agreement includes pre-payment commitments for product sales and distribution of the second-generation multi-cytokine-based HCW11-006 for use as a reagent Akron is a leading supplier of critical ancillary materials and [...]
Applied Biologics Welcomes New CMS RAPID Pathway and Expanded CMS-FDA Coordination for Innovative Medical Technologies
08/09/2026
Company believes earlier alignment of regulatory and Medicare evidence expectations could provide a valuable model for future drug and biologic development SCOTTSDALE, Ariz., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Applied [...]

Pages